Trabectedin Inhibits EWS-FLI1 and Evicts SWI/SNF from Chromatin in a Schedule Dependent Manner

PURPOSE: The successful clinical translation of compounds that target specific oncogenic transcription factors will require an understanding of the mechanism of target suppression to optimize the dose and schedule of administration. We have previously shown trabectedin reverses the gene signature of...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Cancer Res
Main Authors: Harlow, Matt L., Chasse, Maggie H., Boguslawski, Elissa A., Sorensen, Katie M., Gedminas, Jenna M., Kitchen-Goosen, Susan M., Rothbart, Scott B., Taslim, Cenny, Lessnick, Stephen L., Peck, Anderson S., Madaj, Zachary B., Bowman, Megan J., Grohar, Patrick J.
Formato: Artigo
Idioma:Inglês
Publicado em: 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6594545/
https://ncbi.nlm.nih.gov/pubmed/30723142
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-18-3511
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados